BUCCOLIERO, FRANCESCA
BUCCOLIERO, FRANCESCA
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS
2014 Mello, T; Tarocchi, M; Perini, F; Buccoliero, F; Marroncini, G; Ceni, E; Polvani, S; Tempesti, S; Milani, S; Galli, A
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression.
2013 S. Polvani;M. Tarocchi;S. Tempesti;T. Mello;E. Ceni;F. Buccoliero;M. D'Amico;V. Boddi;M. Farsi;S. Nesi;G. Nesi;S. Milani;A. Galli
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model
2011 T. Mello;M. Tarocchi;F. Buccoliero;E. Ceni;S. Polvani;L. Cioni;S. Milani;A. Galli
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1
2012 T. Mello;M. Tarocchi;F. Buccoliero;E. Ceni;S. Polvani;S. Milani;A. Galli
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma
2011 M. Tarocchi;S. Polvani;T. Mello;E. Ceni;F. Buccoliero;L. Cioni;S. Milani;A. Galli
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma
2012 M. Tarocchi;S. Polvani;A. J. Peired;T. Mello;E. Ceni;F. Buccoliero;S. Deiana;C. Parrini;G. Pieraccini;C. Luchinat;I. Bertini;S. Milani;A. Galli
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.
2010 GALLI A; CENI E; MELLO T; POLVANI S; TAROCCHI M; BUCCOLIERO F; LISI F; CIONI L; OTTANELLI B; FORESTA V; MASTROBUONI G; MONETI G; PIERACCINI G; SURRENTI C; MILANI S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS | 2014 | Mello, T; Tarocchi, M; Perini, F; Buccoliero, F; Marroncini, G; Ceni, E; Polvani, S; Tempesti, S; Milani, S; Galli, A | |
| COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. | 2013 | S. Polvani;M. Tarocchi;S. Tempesti;T. Mello;E. Ceni;F. Buccoliero;M. D'Amico;V. Boddi;M. Farsi;S. Nesi;G. Nesi;S. Milani;A. Galli | |
| Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model | 2011 | T. Mello;M. Tarocchi;F. Buccoliero;E. Ceni;S. Polvani;L. Cioni;S. Milani;A. Galli | |
| Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 | 2012 | T. Mello;M. Tarocchi;F. Buccoliero;E. Ceni;S. Polvani;S. Milani;A. Galli | |
| Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma | 2011 | M. Tarocchi;S. Polvani;T. Mello;E. Ceni;F. Buccoliero;L. Cioni;S. Milani;A. Galli | |
| Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma | 2012 | M. Tarocchi;S. Polvani;A. J. Peired;T. Mello;E. Ceni;F. Buccoliero;S. Deiana;C. Parrini;G. Pieraccini;C. Luchinat;I. Bertini;S. Milani;A. Galli | |
| Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. | 2010 | GALLI A; CENI E; MELLO T; POLVANI S; TAROCCHI M; BUCCOLIERO F; LISI F; CIONI L; OTTANELLI B; FORESTA V; MASTROBUONI G; MONETI G; PIERACCINI G; SURRENTI C; MILANI S |